Please use a PC Browser to access Register-Tadawul
Stock Ratings | Sarepta Therapeutics, Inc. (SRPT.US) stock's upside potential remains high at 256.65% despite Morgan Stanley lowering its price target to $182.
Nektar Therapeutics NKTR | 54.70 | +7.00% |
Lovesac Co. LOVE | 13.99 | +10.42% |
Atlassian Corp. Plc Class A TEAM | 162.04 | -0.75% |
Opus Genetics Inc. Ordinary Shares IRD | 2.36 | -3.28% |
Sarepta Therapeutics, Inc. SRPT | 21.53 | -1.01% |
Major US investment bank ratings are used to track the latest valuations and target prices on Wall Street daily, and to explore potential stock investment opportunities.
Today's Key Ratings and Concerns
Jefferies: Upgraded Nektar Therapeutics Nektar Therapeutics(NKTR.US) ) to "Buy", with a price target increase from $1 to $2.
Roth MKM: Maintained a "Buy" rating on Lovesac Co. ( Lovesac Co.(LOVE.US) ), raising the price target from $22 to $28.
Macquarie: Upgraded Atlassian Corp. Plc Class A(TEAM.US) to "Outperform," lowered the price target from $317 to $270.
Craig-Hallum: Initial rating for Opus Genetics ( Opus Genetics Inc. Ordinary Shares(IRD.US) ) with a "Buy" recommendation and a $6 price target.
Morgan Stanley: Maintained Sarepta Therapeutics ( Sarepta Therapeutics, Inc.(SRPT.US) ) rating at “Overweight,” lowered the price target from $196 to $182.
| Investment objective | The symbol | Classification | Target price | Current price | Potential increase/decrease rate | (Classification) Agency |
| Nektar Therapeutics | Nektar Therapeutics(NKTR.US) | to lift | $2.0 | $0.6177 | 223.78% | Jefferies |
| Lovesac Co. | Lovesac Co.(LOVE.US) | to lift | $28.0 | $18.34 | 52.67% | Roth MKM |
| Atlassian Corp. Plc Class A | Atlassian Corp. Plc Class A(TEAM.US) | to lift | $270.0 | $198.37 | 36.11% | Macquarie |
| Axis Capital Holdings Limited | Axis Capital Holdings Limited(AXS.US) | to lift | $119.0 | $92.9 | 28.09% | Jefferies |
| ROOT, INC. | ROOT, INC.(ROOT.US) | to lift | $150.0 | $120.0 | 25.0% | Jefferies |
| Opus Genetics Inc. Ordinary Shares | Opus Genetics Inc. Ordinary Shares(IRD.US) | Initial classification | $6.0 | $0.7085 | 746.86% | Craig-Hallum |
| Sarepta Therapeutics, Inc. | Sarepta Therapeutics, Inc.(SRPT.US) | cut | $182.0 | $51.03 | 256.65% | Morgan Stanley |
| Opal Technologies Inc. Com | Opal Technologies Inc Com(OPAL.US) | cut | $3.5 | $1.36 | 157.35% | Scotiabank |
| Ivanhoe Electric Inc. | Ivanhoe Electric Inc.(IE.US) | cut | $13.0 | $5.36 | 142.54% | JP Morgan |
| Brazil Potash Corp. | Brazil Potash Corp.(GRO.US) | cut | $5.5 | $2.32 | 137.07% | Roth MKM |
comments:
Target price unit and current price: US dollar;
Current Price: As of the latest closing price of US stocks;
Potential increase/decrease ratio = (Agency target price - current price) / current price 100% (Current price = last closing price up to the time of census)
Lifting
UBS: Maintains a "Neutral" rating on Agnico Eagle Mines Agnico-Eagle Mines Limited(AEM.US) ), raising the price target from $110 to $115.
Jefferies: Maintains a "Buy" rating on American American International Group, Inc.(AIG.US) ), raising the price target from $90 to $95.
Wells Fargo: Maintained an "overweight" rating on Arthur J. Gallagher ( Arthur J. Gallagher & Co.(AJG.US) ), raising the price target to $372 from $370.
Barclays: Maintained a "market-matched weight" rating for Arthur J. Gallagher & Co.(AJG.US) ), raising the price target from $308 to $346.
Jefferies: Maintained a "Hold" rating on Aon plc(AON.US) ), raising the price target from $396 to $416.
First coverage
Maxim Group: Initial rating for Allbirds, Inc.(BIRD.US) ) with a "Buy" recommendation and a $14 price target.
Raymond James: Initial rating for Confluent, Inc.(CFLT.US) is "Outperform", with a $30 price target.
Barclays: Awarded an initial rating to Churchill Churchill Downs Incorporated(CHDN.US) ) with an "Overweight" recommendation and a $125 price target.
Mizuho: Initial rating on Costco Wholesale Corporation(COST.US) ) is "Neutral", with a target price of $975.
reduction
Evercore ISI Group: Maintained Acadian Asset Management Inc. Ordinary Shares(AAMI.US) “Market Match” rating, lowered price target to $23 from $25.
Evercore ISI Group: Maintained an “Outperform” rating for AllianceBernstein Holding ( AllianceBernstein Holding L.P.(AB.US) ), while lowering the price target from $41 to $38.
UBS: Maintains Adobe ( Adobe Systems Incorporated(ADBE.US) "Neutral" rating, lowers price target from $410 to $380.
UBS: Maintains 'Neutral' rating on Adient plc(ADNT.US) ), lowers price target from $20 to $13.
Barclays: Maintained an “Overweight” rating on Autodesk ( Autodesk, Inc.(ADSK.US) ), lowering the price target to $325 from $365.
Morgan Stanley: Maintained a “market-weight” rating on AerCap Holdings NV(AER.US) ), lowering the price target to $101 from $112.
Editor's Note: This content was generated by Sahm's AI-powered SaaS tool and reviewed by our editorial team.
Hazard Warning:
Investing involves risks, and securities prices may rise, fall, or even become worthless. Investing does not guarantee profits and may result in losses. Past performance does not necessarily reflect future performance. Before making any investment decision, investors should evaluate their financial situation, investment objectives, experience, and risk tolerance, and understand the nature of the investment products and the risks associated with them. For further details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, you are advised to seek independent professional advice.


